We are thrilled to announce the recipients of this year’s Cancer Pathology Translational Research Grants (CPTRG).
The 2025 competition holds particular significance as this is the first time since 2021 that we were able to run this competition. Due to reductions in the OMPRN budget, our long-standing support for pathology-led research was put on hiatus despite strong and persistent interest from our members. This return of the CPTRG program for one more “hurrah” is an opportunity for us to recognize the curiosity, dedication and collaborative spirit that defines OMPRN members.
This year’s funded projects covered digital and spatial pathology along with AI-driven approaches to diagnostics and biomarker discovery. For more information on these and other projects, please visit our Funded Projects webpage.
Stream 1 Awardees (3)
- Project title: High-Resolution Morphological and Molecular Profiling of Esophageal Adenocarcinoma Using Spatial Transcriptomics and Deep Learning
Principal Investigator: Dr. Sangeetha Kalimuthu (University Health Network) - Project title: Integrative Digital and Spatial Pathology Proteomics Framework for Improved Personalized Prognosis in Testicular Cancer Patients
Principal investigator: Dr. George Yousef (University Health Network) - Project title: Development and Validation of a Novel Artificial Intelligence Algorithm for Accurate Detection of Homologous Recombination Deficiency in High-Grade Serous Ovarian Carcinoma
Principal investigator: Dr. Roman Zyla (Mount Sinai Hospital)
Stream 4 Awardee (1)
- Project title: Validating PTK7 as a Prognostic Marker for Brain Metastasis in Breast Cancer
Principal investigator: Dr. Qi Zhang (London Health Sciences Centre)
Together, these projects exemplify the innovation, inter-disciplinary collaborations and scientific excellence that the CPTRG program was designed to foster. Congratulations to this year’s awardees!
Metrics from the Cancer Pathology Translational Research Grant competition
Cumulative achievements reported by OMPRN-funded investigators from 2016-2025.
Posted on: